Double Blind Placebo Controlled Study of Outpatient Intravenous Ketamine for the Treatment of CRPS - Contacts and Locations

Double Blind Placebo Controlled Study of Outpatient Intravenous Ketamine for the Treatment of CRPS

This study is currently recruiting participants.

Study NCT00579085. Last updated on December 20, 2007. Information provided by Drexel University

Please refer to this study by its ClinicalTrials.gov identifier: NCT00579085

Contacts


Contact: Robert J Schwartzman, MD	215-762-7090	rschwartz@drexelmed.edu

Locations


United States, Pennsylvania
	Drexel University College of Medicine Department of Neurology	Recruiting
	Philadelphia, Pennsylvania, United States, 19107
	Contact: Robert J Schwartzman, MD/Neurology 215-762-7090 rschwartz@drexelmed.edu
	Principal Investigator: Robert J Schwartzman, MD Neurology

Sponsors and Collaborators

Drexel University